A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense Therapy

Journal Title: Transcriptomics: Open Access - Year 2022, Vol 8, Issue 4

Abstract

As of July 25-2020, 643,412 people in more than 215 countries have been victims of the new type of coronavirus, SARS-CoV-2. Thereby, there is a huge effort to develop a strategy to treat, and or prevent people from SARS-CoV-2 infection. Those efforts could be mainly categorized as drug repurposing, anti-SARS-CoV-2 antibodies from people who recovered, and vaccines. However, there is currently no specific treatment available against SARS-CoV-2 infected patients. That`s why many new approaches and ideas are still studied every day for the treatment of SARS-CoV-2 infected patients. Antisense therapy is one of these promising approaches to target SARS-CoV-2 genomic RNA specifically and inhibit its activity upon incorrect viral RNA processing. In this study, Antisense Oligonucleotide (ASO) candidates targeting SARS-CoV-2 genomic RNA were designed. High-scored ASOs with a high potential to inhibit SARS-CoV-2 replication and transcription by inducing cleavage of the viral genomic were determined among ASO candidates. For the future, those promising ASOs can be synthesized followed by required modifications and test on SARS-CoV-2 infected Vero cells to screen their efficacy for the treatment of SARS-CoV-2 infected patients.

Authors and Affiliations

Hasan Cubuk

Keywords

Related Articles

Differential Gene Expression of Threatened Himalayan Snow Trout Challenged With Aeromonashydrophilla

The snow trout (Schizothorax richardsonii) is endemic to the high altitudinal Himalayan region and thrive well in a wide thermal regime (0-27°C). The species can be used as a model species to study the abiotic and biotic...

Significant factors in rectal cancer recurrence

INTRODUCTION The incidence of recurrence of rectal cancer worldwide has shown a significant decline in the last ten years due to the progress of neoadjuvant preoperative chemoradiotherapy and the improvement of surgery....

Transcriptome Analysis in Response to Endurance Exercise in Non-Elite Marathon Runners

Objective: Given that endurance exercise can have a huge impact on nonelite athletes, this study set out to analyze differentially expressed genes and pathways before and after a marathon, then subsequently assess which...

Super-dosing of vitamin B2 induces beneficial hindgut transcriptome responses in weaned piglets

High dietary levels of vitamin B2 on the caecal transcriptome of weaned piglets was explored, to evaluate if super-dosing of riboflavin could reach the hind gut, and consequently trigger a beneficial host response. Caeca...

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense Therapy

As of July 25-2020, 643,412 people in more than 215 countries have been victims of the new type of coronavirus, SARS-CoV-2. Thereby, there is a huge effort to develop a strategy to treat, and or prevent people from SARS-...

Download PDF file
  • EP ID EP743041
  • DOI 10.35248/2329-8936.22.8.119
  • Views 8
  • Downloads 0

How To Cite

Hasan Cubuk (2022). A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense Therapy. Transcriptomics: Open Access, 8(4), -. https://europub.co.uk/articles/-A-743041